[Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Revista de neurología (Ed. impresa)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18214820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• [Benefit of the implementation of on-call neurology physicians in a general hospital].

  2007cited by this paper
• Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association.

  2005cited by this paper
• Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients

  2005cited by this paper
• [Thrombolysis in stroke: inappropriate consideration of the 'window period' as the time available].

  2005cited by this paper
• Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

  2005cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Differential Pattern of Tissue Plasminogen Activator–Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes

  2004cited by this paper
• VA Stroke Study

  2003cited by this paper
• [Intravenous tissue-type plasminogen activator for the treatment of acute cerebral ischemia].

  2003cited by this paper
• Is the Benefit of Early Recanalization Sustained at 3 Months?: A Prospective Cohort Study

  2003cited by this paper
• Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital

  2003cited by this paper
• Public Perception of Stroke in Spain

  2003cited by this paper
• Thrombolysis for acute stroke in routine clinical practice.

  2002cited by this paper
• Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.

  2001cited by this paper
• Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated With Symptomatic Intracerebral Hemorrhage

  2001cited by this paper
• Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice.

  2000cited by this paper
• Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

  2000cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Canadian Hospital’s Experience

  2000cited by this paper
• Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke.

  2000cited by this paper
• Thrombolytic therapy in acute stroke: neurologists, get off your hands!

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.

  1997cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke

  1993cited by this paper

• Garlic-Derived S-allylcysteine Improves Functional Recovery and Neurotrophin Signaling After Brain Ischemia in Female Rats

  2026cites this paper
• [Development and response to intravenous treatment with tissue plasminogen activator with regard to referral hospitals. The experience of a stroke referral unit].

  2012cites this paper
• [Endovenous thrombolysis in a district hospital using the telestroke system].

  2011cites this paper
• [Stroke health care plan (ICTUS II. 2010)].

  2011cites this paper
• [Provincial stroke code: characteristics and impact on health care].

  2011cites this paper
• Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study.

  2010cites this paper
• [Stroke unit: the best treatment for stroke patients].

  2009cites this paper
• Systematic review of stroke thrombolysis service configuration

  2009cites this paper
• [Training and experience in stroke units].

  2008cites this paper
• [Pharmacology of neuroprotection in acute ischemic stroke].

  2008cites this paper
• [Vascular risk factors in patients with ischaemic stroke. Distribution according to age, sex and stroke subtype].

  2008cites this paper